AAP
FBIO icon

Arax Advisory Partners’s Fortress Biotech FBIO Stock Holding History

Arax Advisory Partners’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
+4,086
New +$10.5K ﹤0.01% 4229
2026
Q1 		– Sell
-4,086
Closed -$15K – 3982
2025
Q4 		$15K Buy
4,086
+2,000
+96% +$5.7K ﹤0.01% 2278
2025
Q3 		$7.71K Buy
+2,086
New +$5.27K ﹤0.01% 2708

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Arax Advisory Partners's FBIO Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Fortress Biotech (FBIO) in Q2 2026: 4,086 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #4229 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in FBIO as recently as Q4 2025.

Arax Advisory Partners first reported a position in FBIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $15K in Q4 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Arax Advisory Partners held 4,086 shares of Fortress Biotech worth $12.5K as of Q2 2026.
  • Fortress Biotech was a new Arax Advisory Partners position in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4229 holding.
  • Arax Advisory Partners first reported a position in Fortress Biotech in Q3 2025 and has held it in 3 quarters since.
  • Arax Advisory Partners's Fortress Biotech position peaked at $15K in Q4 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.